Shuqin Dai

798 total citations
40 papers, 575 citations indexed

About

Shuqin Dai is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Shuqin Dai has authored 40 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 15 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Shuqin Dai's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and RNA modifications and cancer (6 papers). Shuqin Dai is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and RNA modifications and cancer (6 papers). Shuqin Dai collaborates with scholars based in China, France and Malaysia. Shuqin Dai's co-authors include Wanli Liu, Yuehao Lin, Junye Wang, Lin Zhang, Xueping Wang, Hao Chen, Huan-he Ni, Jiang Li, He Huang and Minjie Mao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shuqin Dai

35 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuqin Dai China 15 239 198 170 138 96 40 575
Chuanming Zheng China 16 245 1.0× 194 1.0× 194 1.1× 108 0.8× 150 1.6× 56 639
Kai Hu China 17 379 1.6× 196 1.0× 244 1.4× 197 1.4× 141 1.5× 53 794
Ying He China 13 178 0.7× 162 0.8× 135 0.8× 138 1.0× 88 0.9× 54 518
Chuanben Chen China 14 158 0.7× 235 1.2× 74 0.4× 176 1.3× 103 1.1× 61 539
Murat Serilmez Türkiye 15 198 0.8× 238 1.2× 102 0.6× 93 0.7× 59 0.6× 34 570
Oliver J. Stoetzer Germany 14 256 1.1× 206 1.0× 113 0.7× 97 0.7× 55 0.6× 29 625
Yu Heng China 15 212 0.9× 200 1.0× 147 0.9× 140 1.0× 177 1.8× 59 651
Yoshimichi Tanaka Japan 16 350 1.5× 269 1.4× 194 1.1× 87 0.6× 97 1.0× 45 850
Hayahito Nomi Japan 14 246 1.0× 126 0.6× 182 1.1× 172 1.2× 147 1.5× 52 627
Joaquina Martínez-Galán Spain 14 236 1.0× 257 1.3× 180 1.1× 124 0.9× 81 0.8× 36 544

Countries citing papers authored by Shuqin Dai

Since Specialization
Citations

This map shows the geographic impact of Shuqin Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuqin Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuqin Dai more than expected).

Fields of papers citing papers by Shuqin Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuqin Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuqin Dai. The network helps show where Shuqin Dai may publish in the future.

Co-authorship network of co-authors of Shuqin Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Shuqin Dai. A scholar is included among the top collaborators of Shuqin Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuqin Dai. Shuqin Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Shu‐Mei, Dongni Shi, Shuqin Dai, et al.. (2025). RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer. Clinical and Translational Medicine. 15(2). e70203–e70203. 4 indexed citations
2.
Gu, Rui, et al.. (2025). Identification of exosome-related SERPINB1 as a novel predictor for tumor immune microenvironment and clinical outcomes in ovarian cancer. Journal of Ovarian Research. 18(1). 65–65. 1 indexed citations
3.
Dai, Shuqin, et al.. (2024). The Interaction Effect of Obesity with Sleep Duration on Urinary Incontinence in Adult Females: A Cross-Sectional Study of the NHANES Database. Urologia Internationalis. 108(6). 525–538. 1 indexed citations
4.
5.
6.
Wang, Xueping, et al.. (2022). Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy. Journal of Oncology. 2022. 1–11. 3 indexed citations
7.
Lai, Yanzhen, Yu Wang, Yaxian Wu, et al.. (2022). Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules. Cancer Control. 29. 2905522709–2905522709. 9 indexed citations
8.
Xiao, Yunyun, Dongni Shi, Xiaoqing Wang, et al.. (2022). MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma. Cancer Research. 82(22). 4191–4205. 21 indexed citations
9.
Zhai, Wenyu, Fangfang Duan, Li Gong, et al.. (2021). Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9. 769881–769881. 6 indexed citations
10.
Liu, Xiaohua, et al.. (2021). The automated processing algorithm to correct the test result of serum neuron‐specific enolase affected by specimen hemolysis. Journal of Clinical Laboratory Analysis. 35(9). e23895–e23895. 6 indexed citations
11.
He, Yi, Yu Wang, Xueping Wang, et al.. (2020). Applying CRISPR/Cas13 to Construct Exosomal PD‐L1 Ultrasensitive Biosensors for Dynamic Monitoring of Tumor Progression in Immunotherapy. Advanced Therapeutics. 3(10). 34 indexed citations
12.
Ni, Huan-he, Lin Zhang, He Huang, Shuqin Dai, & Jiang Li. (2020). Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer. Journal of Translational Medicine. 18(1). 393–393. 57 indexed citations
13.
Zheng, Xin, Shulin Chen, Linfang Li, et al.. (2018). Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125. Journal of Gynecology Obstetrics and Human Reproduction. 47(6). 227–230. 31 indexed citations
14.
Mao, Minjie, Xueping Wang, Hui Sheng, et al.. (2018). A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients. BMC Cancer. 18(1). 1178–1178. 22 indexed citations
15.
Lai, Yanzhen, Xueping Wang, Tao Zeng, et al.. (2018). Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer. Journal of Cancer. 9(9). 1538–1547. 26 indexed citations
16.
Kong, Yanan, Junye Wang, Wanli Liu, et al.. (2013). Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients. PLoS ONE. 8(2). e57092–e57092. 5 indexed citations
17.
18.
Kong, Yanan, Shuqin Dai, Xinhua Xie, et al.. (2011). High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients. Journal of Cancer Research and Clinical Oncology. 138(2). 275–284. 20 indexed citations
19.
Chen, Hao, et al.. (2010). Significance of combined detection of serum Cyfra21-1 and NSE and Ferritin in diagnosis of lung cancer.. Journal of Tropical Medicine. 10(7). 838–841. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanming Zheng Breakdown of academic impact, for papers by Kai Hu Breakdown of academic impact, for papers by Ying He Breakdown of academic impact, for papers by Chuanben Chen Breakdown of academic impact, for papers by Murat Serilmez Breakdown of academic impact, for papers by Oliver J. Stoetzer Breakdown of academic impact, for papers by Yu Heng Breakdown of academic impact, for papers by Yoshimichi Tanaka Breakdown of academic impact, for papers by Hayahito Nomi Breakdown of academic impact, for papers by Joaquina Martínez-Galán
Rankless by CCL
2026